Cloud Banner

Pharmaceutical

Image

Global Congestive Heart Failure Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Report
  • Sep 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Congestive Heart Failure Market – Industry Trends and Forecast to 2029

Market Size in USD Billion

CAGR - 7.000000000000001% Diagram

Diagram Forecast Period 2021–2029
Diagram Market Size (Base Year) USD 21.00 Billion
Diagram Market Size (Forecast Year) USD 36.08 Billion
Diagram CAGR 7.000000000000001%

Global Congestive Heart Failure Market, By Type (Systolic Heart Failure, Diastolic Failure, Left-Sided Heart Failure, Right-Sided Heart Failure), Stages (Stage I, Stage II, Stage III, Stage IV), Diagnosis (Electrocardiogram, Echocardiogram, MRI, Stress Test, Blood Tests, Cardiac Catheterization, Others), Treatment (Medication, Surgery), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.

Congestive Heart Failure Market Analysis and Size

The global congestive heart failure market is expected to witness significant growth during the forecast period. Rising prevalence of coronary artery disease and heart attack worldwide and emerging markets are the factors responsible for the growth of this market. Growing cases of hypertension, cardiomyopathy, diabetes and hyperthyroidism drives the congestive heart failure market. Medical advancements which involves ongoing drug discovery, and government and non-government organizational initiatives are what that boosts the market growth. COVID-19 also had a major impact on the market growth.

Data Bridge Market Research analyses a growth rate in the global congestive heart failure market in the forecast period 2022-2029. The expected CAGR of global congestive heart failure market is tend to be around 7.0% in the mentioned forecast period. The market was valued at USD 21 billion in 2021, and it would grow upto USD 36.08 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Congestive heart failure is the chronic progressive condition that affects the pumping power of the heart muscles. This condition especially refers to the stage in which fluid build-up around the heart & its wall and causes inefficient pumping of blood. Certain condition which causes the CHF are narrow arteries, hypertension, hyperthyroidism, diabetes, smoking & drinking and hyperlipidaemic diseases, which gradually leaves the heart too weak and stiff. Symptoms of CHF included dyspnoea, fatigue and weakness, swelling in legs, ankles & feet, rapid or irregular heartbeat, reduced ability to exercise, swelling of abdomen and chest pain.  It is of great importance to the healthcare sector and thus is expected to rise high in the forecast period

Congestive Heart Failure Market Scope and Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Type (Systolic Heart Failure, Diastolic Failure, Left-Sided Heart Failure, Right-Sided Heart Failure), Stages (Stage I, Stage II, Stage III, Stage IV), Diagnosis (Electrocardiogram, Echocardiogram, MRI, Stress Test, Blood Tests, Cardiac Catheterization, Others), Treatment (Medication, Surgery), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Aspect Imaging Ltd (Israel), CANON MEDICAL SYSTEMS CORPORATION (Japan), Siemens (Germany), General Electric (U.S.), Hitachi, Ltd. (Japan), Koninklijke Philips N.V. (Netherlands), Neusoft Corporation (China), ESAOTE SPA (Italy), Medtronic (Ireland), OMRON Corporation (Japan), Dexcom, Inc (U.S.), Abbott (U.S.), Masimo (U.S.),

Market Opportunities

  • Increased Incidence of Congestive Heart Failure

Global Congestive Heart Failure Market Dynamics

Drivers

  • Increased Initiatives by Government and Market Players

The increasing number of efforts and initiatives that are being initiated by the government and major market leaders all over the world are boosting the market growth. Governments in many countries have launched several healthcare schemes, which, a patient can use for the treatment of several disorders. Furthermore, congestive heart failure being a fatal disease, becoming the reason of mortality for the people all over the world each year. Thus, these policies drive the market growth.

  • Rising Demand for Oral Drugs

Oral drugs is expected to boost the market growth. The segment is expected to accelerate the global market as most products are available in capsule and tablet form and it is a very feasible route of administration.

Opportunities

  • Increased Incidence of Congestive Heart Failure

As per the records of Organ Procurement and Transplantation Network, 3,582 candidates were on the waiting list for heart transplantation as of June 2020 in the U.S. Thus, increase in number of patient suffering from heart failure has increased the demand for many technologies such as ventricular assist devices, which is anticipated to boost the growth of the market. This creates more opportunity in the market.

Restraints/Challenges

  • Lack of Skilled Professionals

Lack of trained professionals who are unaware of the knowledge of the treatment methods for this disease could curb the growth of the global congestive heart failure market over a forecast period.

  • Increasing Cost of Devices

One of the primary factors that are causing a restrain to the congestive heart failure market is the high cost of the devices that occur in installing and operating these devices. There is an increasing number of people that suffers from cardiac disorders all over the world and majority of the population cannot get the optimum benefit of the treatment due to the rising cost.  

This global congestive heart failure market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global congestive heart failure market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Congestive Heart Failure Market        

Considering the present scenario, COVID-19 has left an unprecedented global public health crisis that has impacted practically every business. Transition of healthcare infrastructure toward managing COVID-19 has led to drug launch cancellations and delays in clinical trials. As per the reports from the American College of Cardiology, surveys were submitted from 909 inpatient and outpatient centers who performed cardiac diagnostic procedures in 108 countries. It was witnessed that the procedure volumes decreased 42% from March 2019 to March 2020, and 64% from March 2019 to April 2020. Thus, decline in number of cardiac surgeries has led to decline in congestive heart failure market forecast.

But, in the post-pandemic era, the market is expected to flourish with the increasing upliftments of hospitals and clinics and the reduction of COVID-19 treatment methods.

Global Congestive Heart Failure Market Scope

The global congestive heart failure market is segmented on the basis of type, stage, diagnosis, treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Systolic Heart Failure
  • Diastolic Failure
  • Left-Sided Heart Failure
  • Right-Sided Heart Failure

Stage

  • Stage I
  • Stage II
  • Stage III
  • Stage IV

Diagnosis

  • Electrocardiogram
  • Echocardiogram
  • MRI, Stress Test
  • Blood Tests
  • Cardiac Catheterization
  • Others

Treatment

  • Medication
  • Surgery

Route of Administration

  • Oral
  • Parenteral
  • Others

End-Users

  • Hospitals
  • Homecare
  • Speciality Centres
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Congestive Heart Failure Market Regional Analysis/Insights

The global congestive heart failure market is analysed and market size insights and trends are provided by type, stage, diagnosis, treatment, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global congestive heart failure market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to have the highest market growth due to increased geriatric population, and presence of key manufacture of the product. Europe is considered second largest market for congestive heart failure due to high research and development and healthcare expenditure and skilled professionals.

Asia-Pacific dominates the market due to increased prevalence of coronary heart diseases and related disorders and number of generic drugs.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Congestive Heart Failure Market Share Analysis

The global congestive heart failure market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global congestive heart failure market.

Key players operating in the global congestive heart failure market include:

  • Aspect Imaging Ltd (Israel)
  • CANON MEDICAL SYSTEMS CORPORATION (Japan)
  • Siemens (Germany)
  • General Electric (U.S.)
  • Hitachi, Ltd. (Japan)
  • Koninklijke Philips N.V. (Netherlands)
  • Neusoft Corporation (China)
  • ESAOTE SPA (Italy)
  • Medtronic (Ireland)
  • OMRON Corporation (Japan)
  • Dexcom, Inc (U.S.)
  • Abbott (U.S.)
  • Masimo (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The global congestive heart failure market is expected USD 36.08 billion by forecast.
The global congestive heart failure market is projected to grow at a CAGR of 7% during the forecast period of 2022-2029.
The major players operating in the Congestive Heart Failure Market are Aspect Imaging Ltd (Israel), CANON MEDICAL SYSTEMS CORPORATION (Japan), Siemens (Germany), General Electric (U.S.), Hitachi, Ltd. (Japan), Koninklijke Philips N.V. (Netherlands), Neusoft Corporation (China), ESAOTE SPA (Italy), Medtronic (Ireland), OMRON Corporation (Japan), Dexcom, Inc (U.S.), Abbott (U.S.), Masimo (U.S.).
The major countries covered in the Congestive Heart Failure Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials